Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.

Item
http://www.wikidata.org/entity/Q44652111
KIT D816V and JAK2 V617F mutations are seen recurrently in hypereosinophilia of unknown significance.Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin.Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia.Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal.Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.Imatinib for the treatment of hypereosinophilic syndromes.Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation.Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms.Guideline for the investigation and management of eosinophilia.
P2860

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.

Item
http://www.wikidata.org/entity/Q44652111
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Long-term follow-up of treatme ...... rearrangements in blast phase.
@en
Long-term follow-up of treatme ...... rearrangements in blast phase.
@nl
type
label
Long-term follow-up of treatme ...... rearrangements in blast phase.
@en
Long-term follow-up of treatme ...... rearrangements in blast phase.
@nl
prefLabel
Long-term follow-up of treatme ...... rearrangements in blast phase.
@en
Long-term follow-up of treatme ...... rearrangements in blast phase.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Long-term follow-up of treatme ...... rearrangements in blast phase.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698